HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Chardin Selected Research

David Chardin Research Topics

Disease

6Neoplasms (Cancer)
01/2022 - 12/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2020
2Breast Neoplasms (Breast Cancer)
01/2020 - 12/2019
1Gastritis
01/2022
1Parkinsonian Disorders (Parkinsonism)
01/2022
1Inflammation (Inflammations)
01/2022
1Lung Neoplasms (Lung Cancer)
12/2021
1Carcinoma (Carcinomatosis)
10/2021
1Ductal Carcinoma
12/2019
1Body Weight (Weight, Body)
12/2019
1Glioblastoma (Glioblastoma Multiforme)
01/2019
1Brain Neoplasms (Brain Tumor)
01/2019
1Residual Neoplasm
01/2019
1Lipid Pneumonia
06/2017
1Xeroderma Pigmentosum (Kaposi's Disease)
06/2017

Drug/Important Bio-Agent (IBA)

4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 06/2017
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
2Biological ProductsIBA
01/2020 - 12/2019
1Immune Checkpoint InhibitorsIBA
01/2022
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2021
1Death Domain ReceptorsIBA
01/2020
1Blood Glucose (Blood Sugar)IBA
12/2019
1Estrogen ReceptorsIBA
12/2019
1Bevacizumab (Avastin)FDA Link
01/2019
1LipidsIBA
06/2017
1Pharmaceutical PreparationsIBA
06/2017

Therapy/Procedure

2Immunotherapy
01/2022 - 01/2020
2Therapeutics
01/2020 - 12/2019
2Drug Therapy (Chemotherapy)
01/2020 - 01/2019
1Denervation
01/2022
1Neoadjuvant Therapy
12/2019
1Aftercare (After-Treatment)
01/2019